To: Board of Supervisors
From: Dr. Grant Colfax, Health Services Director
Report Title: Rescind Prior Board Action Pertaining to a Purchase Order with Priority Healthcare Distribution, Inc. (dba Curascript Specialty Distribution)
?Recommendation of the County Administrator ? Recommendation of Board Committee
RECOMMENDATIONS:
Rescind prior Board action of July 14, 2026 (C.32), which pertained to a purchase order with Priority Healthcare Distribution, Inc. (dba Curascript Specialty Distribution); and APPROVE and AUTHORIZE the Purchasing Agent, or designee, to execute on behalf of the Health Services Director, a purchase order with Priority Healthcare Distribution, Inc. (dba Curascript Specialty Distribution) in an amount not to exceed $379,835 for the purchase of the opioid use disorder medication Sublocade for Contra Costa Detention Health for the period from July 1, 2026 through June 30, 2029.
FISCAL IMPACT:
Approval of this action will result in expenditures of up to $379,835 over a three-year period and will be funded by the Opioid Settlement Funds.
BACKGROUND:
Priority Healthcare Distribution, Inc. is a pharmaceutical company that provides Sublocade that is used for Opioid Use Disorders (OUD). Contra Costa Detention Health will treat patients with OUD and a history of diversion within the Detention setting utilizing Sublocade Injectable. Treatment with Sublocade is effective in reducing withdrawal symptoms and craving for ongoing opiate abuse. In addition, the use of Sublocade will eliminate patients with OUD and diversion from being detoxed off the medication and, therefore, potentially overdosing on Fentanyl within the detention setting. Contra Costa Detention Health will be reimbursed for the costs incurred for the implementation of medication assisted treatment for the Incarcerated Population utilizing Sublocade.
On May 30, 2025, the Purchasing Agent issued Purchase Order #32757 with Priority Healthcare Distribution, Inc (dba Curascript Specialty Distr...
Click here for full text